Actionnariat et activité des initiés pour Elutia Inc (ELUT): transactions des initiés, déclarations de trading du Sénat et de la Chambre américaine et actions en circulation. Suivez comment dirigeants et politiciens négocient le titre.
Prix
| Prix | $0.81 |
| Capitalisation | $36M |
| Bourse | NASDAQ |
| Pays | US |
Bilan (10 ans)
| Année | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Trésorerie | $2.4M | $2.5M | $39.1M | $30.4M | $17.0M | $19.3M | $13.2M | $36.4M |
| Placements à Court Terme | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Créances | $7.2M | $7.2M | $7.2M | $6.0M | $17.6M | $6.0M | $7.0M | $14.6M |
| Stocks | $7.5M | $7.2M | $10.1M | $9.6M | $4.2M | $3.9M | $1.9M | $2.6M |
| Actifs Courants | $18.1M | $18.4M | $59.7M | $47.4M | $50.7M | $31.3M | $26.2M | $55.8M |
| Immobilisations Corporelles | $870000 | $988000 | $1.2M | $1.2M | $565000 | $504000 | $850000 | $5.0M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Actifs Incorporels | 0 | $25.3M | $21.9M | $18.5M | $15.1M | $11.7M | $2.6M | $1.5M |
| Actifs Totaux | $47.7M | $44.8M | $82.8M | $67.2M | $68.8M | $43.4M | $36.1M | $62.4M |
| Dettes Fournisseurs | $1.6M | $2.5M | $2.1M | $1.6M | $1.4M | $3.2M | $4.1M | $4.8M |
| Dette à Court Terme | $6.5M | $5.9M | $12.8M | $12.8M | 0 | $3.3M | $1.2M | $4.8M |
| Passifs Courants | $13.3M | $18.3M | $26.8M | $26.0M | $42.6M | $43.0M | $37.8M | $25.1M |
| Dette à Long Terme | $75.9M | $19.6M | $17.8M | $10.4M | $24.3M | $20.4M | $22.6M | $2.8M |
| Passifs Totaux | $91.1M | $99.9M | $62.0M | $53.6M | $73.9M | $82.0M | $82.4M | $34.7M |
| Réserves | -$45.0M | -$56.9M | -$80.3M | -$105.1M | -$138.0M | -$175.6M | -$229.6M | -$176.2M |
| Capitaux Propres | -$43.4M | -$55.1M | $20.8M | $13.5M | -$5.0M | -$38.6M | -$46.3M | $27.7M |
| Dette Totale | $82.4M | $25.5M | $30.6M | $23.2M | $25.4M | $24.0M | $24.0M | $11.2M |
| Dette Nette | $80.0M | $23.0M | -$8.5M | -$7.2M | $8.5M | $4.7M | $10.8M | -$25.2M |
| Fonds de Roulement | $4.8M | $172000 | $32.9M | $21.4M | $8.1M | -$11.8M | -$11.6M | $30.7M |
Santé financière
| Dette / Capitaux propres | 0.69 |
| Ratio de liquidité | 1.77 |
| Piotroski F-Score | 5 |
| Altman Z-Score | -3.65 |
Rentabilité
| Rentabilité des capitaux propres | 940.81% |
| Rentabilité du capital investi | -79.27% |
| Rentabilité des actifs | 118.69% |
| Marge brute | 57.82% |
| Marge opérationnelle | -194.03% |
| Marge nette | 426.93% |
Entreprises liées: ANVS · BCAB · CALC · CELU · LTRN · MAIA · PYPD
Explorer le secteur: Healthcare · Biotechnology
Plus de sections de ELUT: Vue d'ensemble · Financiers · Valorisation · Statistiques · Estimations · Technique · Actualités · Événements
Découvrir plus: Radar — signaux d'actions sous-évaluées · Académie d'Investissement — apprenez à analyser les actions